
ASTRANA HEALTH INC
ASTHNASDAQTrading Snapshot
- Day Range
- $34.36 β $35.09
- 52-Week Range
- $18.08 β $51.60
- Volume
- $2.45B
- Avg Volume
- $1.94B
- Shares Outstanding
- 49.6M
- Next Earnings
- Oct 18, 2026
Fundamentals Snapshot
- Annual Revenue
- $3.18B
- Last Q Revenue
- $973M
- P/E Ratio
- 61.2
- P/S Ratio
- 0.5x
- EPS (TTM)
- $0.61
- Dividend Yield
- 0.14%
Why Investors Own ASTH
- βHigh-growth profile β revenue up +18.8% YoY with expanding US Equity exposure.
- βHealthy economics β 76% gross margin and 20% free-cash-flow margin.
- βNew products and segments could unlock additional revenue streams.
Execution delays, intensifying competition, and valuation compression if growth decelerates.
Financial Trends
About ASTRANA HEALTH INC
Astrana Health, Inc., which rebranded from Apollo Medical Holdings, Inc. in February 2024, is a healthcare management firm based in Alhambra, California, founded in 1985. This company delivers medical services throughout the United States, operating with a physician-centered approach powered by advanced technology. Its operations are structured across three distinct divisions: Care Partners, Care Delivery, and Care Enablement. Astrana Health utilizes its exclusive platform for population health management and healthcare delivery to implement an integrated, value-based care model. This strategic approach empowers the healthcare providers within its network to offer high-quality care to their patients. The organization provides extensive care coordination services to a broad spectrum of stakeholders, including patients, their families, primary care physicians, specialists, acute care hospitals, other inpatient facilities, physician groups, and health plans. Its robust physician network encompasses primary care doctors, specialized practitioners, advanced practice providers (extenders), and hospital-based physicians. Astrana Health serves a diverse patient base, primarily those with insurance coverageβsuch as private plans, Medicare, Medicaid, and HMOsβbut also extends care to uninsured individuals.
Otter Score Breakdown
βAnalyst Price Target
βLatest News & Updates
ASTRANA HEALTH INC tops quarterly estimates as demand accelerates
Revenue grew double digits with management guiding above consensus; margins continued to expand.
Analysts lift ASTH price targets on improving margins
Several firms raised targets, citing stronger free cash flow and a healthier backlog.
ASTRANA HEALTH INC announces new agreement to expand its footprint
The move broadens the companyβs reach and could add incremental revenue over the next year.